A2M has CFDA BAL is yet to secure SAMR (CFDA) but it's just a matter of time! I believe BAL has more potential for a big upswing. If you don't like risks, A2M is probably less risky.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025